跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 146,325 条关于
“high-grade serous disease”
全部
146,325
临床试验
115,479
药物
2,037
机构
451
资讯
28,358
11年前
PARP Inhibitors Show Promise in Epithelial Ovarian and Breast Cancers with BRCA1/2 Mutations
2年前
Targeted Therapies Show Promise in High-Grade Serous Ovarian Cancer Treatment
去年
Breakthrough Study Reveals Hidden Cancer Cells in 42% of Ovarian Cancer Patients in Clinical Remission
去年
PD-L1 Expression Correlates with HRD Status and Predicts Survival in High-Grade Serous Ovarian Cancer
去年
Avutometinib Plus Defactinib NDA Filed for KRAS-Mutant Low-Grade Serous Ovarian Cancer
3年前
Avutometinib-Defactinib Combination Shows 45% Response Rate in Low-Grade Serous Ovarian Cancer
13年前
Temozolomide's Effectiveness in Treating High Grade Glioma
去年
Ribociclib-Letrozole Combo Shows Promising 24% Response Rate in Low-Grade Serous Ovarian Cancer Trial
3年前
Avutometinib Plus Defactinib Shows Promise in Recurrent Low-Grade Serous Ovarian Cancer
去年
Verastem Oncology Completes FDA Submission for Avutometinib Plus Defactinib in Recurrent KRAS Mutant Low-Grade Serous Ovarian Cancer
第 1 页，共 2836 页
上一页
下一页
